NCT03707652View on ClinicalTrials.gov

Open-label Study to Assess Increasing Levels of NAD+(Nicotinamide Adenine Dinucleotide)

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 12, 2018

Primary Completion Date

May 16, 2018

Study Completion Date

May 24, 2018

Conditions
Increase in Blood Levels of Nicotinamide Adenine Dinucleotide (NAD+)
Interventions
DIETARY_SUPPLEMENT

Oral supplement A

1, 2 or 4 capsules daily of oral supplement A for 3 days

DIETARY_SUPPLEMENT

Oral supplement B

4 capsules daily of oral supplement B for 3 days

DIETARY_SUPPLEMENT

Oral supplement C

1,2 or 4 capsules daily of oral supplement C for 3 days

DIETARY_SUPPLEMENT

Oral supplement D

1 or 2 tablets daily of oral supplement D for 3 days

DIETARY_SUPPLEMENT

Oral Supplement D in combination with oral supplement C

1 or 2 tablets of oral supplement D in combination with 2 or 4 capsules of oral supplement C for 3 days

Trial Locations (1)

33308

Life Extension Clinical Research, Inc., Fort Lauderdale

All Listed Sponsors
lead

Supplement Formulators, Inc.

INDUSTRY

NCT03707652 - Open-label Study to Assess Increasing Levels of NAD+(Nicotinamide Adenine Dinucleotide) | Biotech Hunter | Biotech Hunter